Hi,
Has anyone with node negative has been recommended 3rd generation chemo?
3rd generation :
TAC x 6
CA x 4 then T x4
FEC x 4 then T x8
FEC x 3 then D x 3
(D= Docetaxel) (T=Taxotere)
What do your oncologist think about it?
Thank you.
| Posts 1 - 5 (5 total) | |
|---|---|
|
nash Joined: May 2007 Posts: 1571 |
Jun 23, 2008 09:00 pm
nash wrote:
I'm node negative, and my onc recommended TACx6. The second opinion onc and the surgeon both said that was overkill, and recommended ACx4. I felt that wasn't enough, so went with a middle ground 2nd generation chemo of CAFx6. Dx June 2007, age 38, Stage IIa 2.7 cm pleomorphic ILC, ER+/PR+ HER2-, CAFx6, rads, tamox
|
|
andrew_van Joined: May 2008 Posts: 27 |
Jun 24, 2008 06:49 pm
andrew_van wrote:
Hi, I got the same problem. He said that 3rd regimen would be overkill so she got CEF x 6. But I heard that for example that FEC x 3 follow but D x 3 is a third regimen and is better than CEF. Also less long term side-effects because there is two group (FEC and D). Chemo is complecated and I guess this is why oncologist as their own guide sometimes. They would go crazy if they start analysing every possibities. |
|
nash Joined: May 2007 Posts: 1571 |
Jun 24, 2008 06:59 pm
nash wrote:
Andrew, I've been told and have also read that the overkill part of the equation for node negative is are the taxanes. I think the FEC x3 D x3 is an interesting approach, however, and I wonder if it's a relatively new way to dose. It wasn't offered to me last August when I started chemo, but sounds like something I would have considered. And you're right--chemo is complicated. I'm not sure how we're supposed to make decisions about it when the oncs can't agree amongst themselves. Dx June 2007, age 38, Stage IIa 2.7 cm pleomorphic ILC, ER+/PR+ HER2-, CAFx6, rads, tamox
|
|
LisaSDCA Joined: Jan 2007 Posts: 1562 |
Jun 24, 2008 07:25 pm
LisaSDCA wrote:
I'm node negative but I did do 3rd gen. and I welcomed it! I did TACx6 and would have taken anything stronger if a 4th gen. had happened down the pike at the last minute. Node neg. is not the only variable to look at. I am triple negative - many oncologists view that as equivalent to a positive node. Also, the nodes are not the only avenue for spread beyond the primary tumor. A careful reading of the pathology report can indicate whether there was any lymphatic/vascular invasion in the area of the tumor bed itself. In my case it was absent in one and present in the other. Another telling variable is the Grade of the carcinoma. A Grade 1 indicates a slow-growing, well-differentiated tumor cell. A Grade 3, even in a tumor of the same size, location, node neg, etc. is an entirely different beast. It indicates poorly differentiated cells, likely to be highly aggressive and fast growing. Add in a pre-menopausal patient and there's even greater llikelihood of an aggrresive tumor. These are just some of the factors that might be used in suggesting a Gen.3 protocol in node neg. breast cancer, even w/ small tumors - and why some of us might jump at the opportunity. I do like it when an oncologist thoroughly analyzes the possibilites. Dx 1/24/2007, IDC, 2cm, Stage II, Grade 3, 0/5 nodes, ER-/PR-, HER2- |
|
nash Joined: May 2007 Posts: 1571 |
Jun 25, 2008 12:56 pm
nash wrote:
You're absolutely right, Lisa. High-risk node negative bc calls for a taxane. Thanks for bringing that up. My situation was so solidly in the grey area that it took 4 trips to tumor board and a call by my onc to UCLA to decide what to do with my chemo. I was young, had a large tumor of a rare, clinically aggressive subtype, yet had negative nodes, hormone positive, grade 2, oncotype 18. My second opinion onc walked in the room upon our first meeting, looked at me and said, "You're a conundrum". Terrific. Anyhow, ultimately the consensus was that risk of a taxane outweighed the benefit in my case. Dx June 2007, age 38, Stage IIa 2.7 cm pleomorphic ILC, ER+/PR+ HER2-, CAFx6, rads, tamox
|
© 2009 Breastcancer.org. All rights reserved.